Patient characteristics and reasons for discontinuation in a cardiovascular risk management programme in The Netherlands
Tóm tắt
Since 2010, an increasing number of patients have participated in a nurse-led integrated cardiovascular risk management programme in the Netherlands. Because it is important to understand which patients discontinue and why, when evaluating the effectiveness of the care programme, the aim was to identify the reasons for discontinuation. Electronic health records of 3997 patients enrolled in a nurse-led integrated cardiovascular risk management programme that started on April 1st, 2010, were manually scrutinized for reasons for discontinuation between April 1st, 2010, and April 1st, 2018. In addition to death and moving to a diabetes care programme, we describe 7 different reasons why patients discontinued the programme and compared the patient characteristics of those who discontinued the programme without specific reasons with those who remained in the care programme for 8 years. Between April 1st, 2010, and April 1st, 2018, 1,190 participants (29.8%) discontinued the CVRM care programme, of whom 271 participants died (6.8%) and 195 were transferred to a diabetes care programme (4.9%). The remaining 724 patients (18.1%) participated 5 years before discontinuation. Of these, 67 (9.3%) had a previous cardiovascular event at the start of the programme. In 355 patients, a specific reason for discontinuation was not found. At baseline, these patients less frequently had a history of CVD than those who continued the programme for 8 years (1.7 vs. 22.6%), were younger (62 vs. 67 years), had less registered cardiovascular comorbidity (atrial fibrillation: 1.1 vs. 7.2%; congestive heart failure 0.3 vs. 1.2%; chronic kidney disease 0.0 vs. 4.5%), were more often smokers (13.0% vs. 4.3%) and took blood pressure- and lipid-lowering drugs twice as often. In our study we observed that participants who discontinued the nurse-led integrated CVRM care programme between 2010 and 2018 without specific reason or on request were younger, without previous CVD, had less cardiovascular comorbidity and were better adjusted to medication. Exploring the patients’ reasons for discontinuation can contribute to an individualized approach to prevent or reduce discontinuation.
Tài liệu tham khảo
v Til JT, de Wildt JE, Struis JN. De organisatie van zorggroepen anno 2010. Huidige stand van zaken en de ontwikkelingen in de afgelopen jaren. RIVM rapport 260332001/2010.
Resurrección DM, Moreno-Peral P, Gómez-Herranz M, Rubio-Valera M, Pastor L, Caldas de Almeida JM, Motrico E. Factors associated with nonparticipation in and dropout from cardiac rehabilitation programmes: a systematic review of prospective cohort studies. Eur J Cardiovasc Nurs. 2019;18(1):38–47. https://doi.org/10.1177/1474515118783157.
Pardaens S, De Smedt D, De Bacquer D, Willems AM, Verstreken S, De Sutter J. Comorbidities and Psychosocial Characteristics as Determinants of Dropout in Outpatient Cardiac Rehabilitation. J Cardiovasc Nurs. 2017 Jan/Feb;32(1):14–21. https://doi.org/10.1097/JCN.0000000000000296. PMID: 26422639.
De Vos C, Li X, Van Vlaenderen I, Saka O, Dendale P, Eyssen M, Paulus D. Participating or not in a cardiac rehabilitation programme: factors influencing a patients decision. Eur J Prev Cardiol. 2013;20(2):341–8. https://doi.org/10.1177/2047487312437057.
Turk-Adawi KI, Oldridge NB, Tarima SS, Stason WB, Shepard DS. Cardiac rehabilitation patient and organizational factors: what keeps patients in programs? J Am Heart Assoc. 2013;2(5):e000418. https://doi.org/10.1161/JAHA.113.000418. PMID: 24145743; PMCID: PMC3835256.
Pardaens S, Willems AM, Clays E, Baert A, Vanderheyden M, Verstreken S, Du Bois I, Vervloet D, De Sutter J. The impact of drop-out in cardiac rehabilitation on outcome among coronary artery disease patients. Eur J Prev Cardiol. 2017;24(14):1490–7. https://doi.org/10.1177/2047487317724574.
Dibao-Dina C, Angoulvant D, Lebeau JP, Peurois JE, Abdallah El Hirtsi K, Lehr-Drylewicz AM. Patients’ adherence to optimal therapeutic, lifestyle and risk factors recommendations after myocardial infarction: six years follow-up in primary care. PLoS ONE. 2018;13(9):e0202986. https://doi.org/10.1371/journal.pone.0202986. PMID: 30180180; PMCID: PMC6122779.
Kotseva K, Wood D, De Bacquer D, EUROASPIRE investigators. Determinants of participation and risk factor control according to attendance in cardiac rehabilitation programmes in coronary patients in Europe: EUROASPIRE IV survey. Eur J Prev Cardiol. 2018;25(12):1242–51. https://doi.org/10.1177/2047487318781359.
Smits GH, Van Doorn S, Bots ML, Hollander M. Stepwise implementation of a cardiovascular risk management program in primary care. BMC Fam Pract. 2022;23:1. https://doi.org/10.1186/s12875-021-01602-w.
Smulders YM, Burgers JS, Scheltens T, van Hout BA, Wiersma T, Simoons ML. Guideline development group for the Dutch guideline for multidisciplinary cardiovascular risk management. Clinical practice guideline for cardiovascular risk management in the Netherlands. Neth J Med. 2008;66(4):169–74. Review. PubMed PMID: 18424866.
Badenbroek IF, Nielen MMJ, Hollander M, Stol DM, de Wit NJ, Schellevis FG. Characteristics and motives of nonresponders in a stepwise cardiometabolic disease prevention program in primary care. Eur J Public Health. 2021;31(5):991–6. https://doi.org/10.1093/eurpub/ckab060. PMID: 33970254; PMCID: PMC8565495.
Badenbroek IF, Nielen MMJ, Hollander M, Stol DM, Drijkoningen AE, Kraaijenhagen RA, de Wit NJ, Schellevis FG. Mapping nonresponse in a prevention program for cardiometabolic diseases in primary care: how to improve participation? Prev Med Rep. 2020;19:101092. https://doi.org/10.1016/j.pmedr.2020.101092. PMID: 32461878; PMCID: PMC7240717.
De Bacquer D, Astin F, Kotseva K, Pogosova N, De Smedt D, De Backer G, Rydén L, Wood D, Jennings C, EUROASPIRE IV and V surveys of the European Observational Research Programme of the European Society of Cardiology. ;. Poor adherence to lifestyle recommendations in patients with coronary heart disease: results from the EUROASPIRE surveys. Eur J Prev Cardiol. 2022;29(2):383–395. https://doi.org/10.1093/eurjpc/zwab115. PMID: 3429312.
McKee G, Biddle M, O’ Donnell S, Mooney M, O’ Brien F, Moser DK. Cardiac rehabilitation after myocardial infarction: what influences patients’ intentions to attend? Eur J Cardiovasc Nurs. 2014;13(4):329–37. https://doi.org/10.1177/1474515113496686.
Connolly SB, Kotseva K, Jennings C, Atrey A, Jones J, Brown A, Bassett P, Wood DA. Outcomes of an integrated community-based nurse-led cardiovascular disease prevention programme. Heart. 2017;103(11):840–7. https://doi.org/10.1136/heartjnl-2016-310477.
van Engen-Verheul M, de Vries H, Kemps H, Kraaijenhagen R, de Keizer N, Peek N. Cardiac rehabilitation uptake and its determinants in the Netherlands. Eur J Prev Cardiol. 2013;20(2):349–56. https://doi.org/10.1177/2047487312439497.
Turk-Adawi KI, Oldridge NB, Tarima SS, Stason WB, Shepard DS. Cardiac rehabilitation enrollment among referred patients: patient and organizational factors. J Cardiopulm Rehabil Prev. 2014 Mar-Apr;34(2):114 – 22. https://doi.org/10.1097/HCR.0000000000000017. PMID: 24142042.
Beauchamp A, Worcester M, Ng A, Murphy B, Tatoulis J, Grigg L, Newman R, Goble A. Attendance at cardiac rehabilitation is associated with lower all-cause mortality after 14 years of follow-up. Heart. 2013;99(9):620–5. https://doi.org/10.1136/heartjnl-2012-303022.
Doll JA, Hellkamp A, Ho PM, Kontos MC, Whooley MA, Peterson ED, Wang TY. Participation in Cardiac Rehabilitation Programs Among Older Patients After Acute Myocardial Infarction. JAMA Intern Med. 2015;175(10):1700-2. https://doi.org/10.1001/jamainternmed.2015.3819. PMID: 26237309.
Ruano-Ravina A, Pena-Gil C, Abu-Assi E, Raposeiras S, van ‘t Hof A, Meindersma E, Bossano Prescott EI, González-Juanatey JR. Participation and adherence to cardiac rehabilitation programs. A systematic review. Int J Cardiol. 2016;223:436–43. https://doi.org/10.1016/j.ijcard.2016.08.120.
Parashar S, Spertus JA, Tang F, Bishop KL, Vaccarino V, Jackson CF, Boyden TF, Sperling L. Predictors of early and late enrollment in cardiac rehabilitation, among those referred, after acute myocardial infarction. Circulation. 2012;126(13):1587–95. https://doi.org/10.1161/CIRCULATIONAHA.111.088799. Epub 2012 Aug 28. PMID: 22929302.
Rao A, Zecchin R, Byth K, Denniss AR, Hickman LD, DiGiacomo M, Phillips JL, Newton PJ. The role of Lifestyle and Cardiovascular Risk factors in Dropout from an Australian Cardiac Rehabilitation Program. A longitudinal cohort study. Heart Lung Circ. 2021;30(12):1891–900. Epub 2021 Jul 1. PMID: 34219025.
Jones M, Jolly K, Raftery J, Lip GY, Greenfield S, BRUM Steering Committee. DNA’ may not mean ‘did not participate’: a qualitative study of reasons for nonadherence at home- and centre-based cardiac rehabilitation. Fam Pract. 2007;24(4):343–57. https://doi.org/10.1093/fampra/cmm021.
Fullerton B, Erler A, Pöhlmann B, Gerlach FM. Predictors of dropout in the German disease management program for type 2 diabetes. BMC Health Serv Res. 2012;12:8. https://doi.org/10.1186/1472-6963-12-8. PMID: 22233930; PMCID: PMC3330004.
Gucciardi E, Demelo M, Offenheim A, Stewart DE. Factors contributing to attrition behavior in diabetes self-management programs: a mixed method approach. BMC Health Serv Res. 2008;8:33. https://doi.org/10.1186/1472-6963-8-33. PMID: 18248673; PMCID: PMC2277391.
Pimouguet C, Le Goff M, Thiébaut R, Dartigues JF, Helmer C. Effectiveness of disease-management programs for improving diabetes care: a meta-analysis. CMAJ. 2011;183(2):E115–27. https://doi.org/10.1503/cmaj.091786.
Nielen MMJ, Hek K, Weesie YM, Davids R. J.C. Korevaar. Hoe vaak hebben nederlanders contact met de Huisartsenpraktijk? Zorggebruik in De Huisartsenpraktijk in 2019. Utrecht: Nivel; 2020.
Herrera PA, Moncada L, Defey D. Understanding Non-adherence from the Inside: hypertensive patients’ motivations for adhering and not adhering. Qual Health Res. 2017;27(7):1023–34. Epub 2016 Jun 9. PMID: 27282381.
Sin NL, Kumar AD, Gehi AK, Whooley MA. Direction of Association between Depressive Symptoms and lifestyle behaviors in patients with Coronary Heart Disease: the Heart and Soul Study. Ann Behav Med. 2016;50(4):523–32. https://doi.org/10.1007/s12160-016-9777-9. PMID: 26817654; PMCID: PMC4935549.